Zogenix reports positive results from sumatriptan DosePro studyPharmaceutical Business Review - 17 minutes agoThe second study, in which patients at home used sumatriptan DosePro as their primary means of treating migraine headache, demonstrated that 98% of patients …
Original post by FDA "pain relief" pharmaceutical - Google News
0 Responses to “Zogenix reports positive results from sumatriptan DosePro study - Pharmaceutical Business Review”